Oxford BioTherapeutics at BIO-Europe 2026

Nov 9–11, 2026 Cologne, Germany ~5.8k attendees Website

Oxford BioTherapeutics at BIO-Europe 2026 in Cologne: 1 session (1 panel discussion).

OrganizationBIO-Europe 2026 Attendance
oxfordbiotherapeutics.com
Biotech
Clinical-stage oncology company developing antibody-drug conjugates and antibodies against novel cancer targets.
Panel
Mon Nov 9
14:00–14:45
ADCs in oncology: What does the data show?
What the latest data show on how well and how safely antibody–drug conjugates treat cancer, and which technologies and targets attract investors.
with Seroba, GSK, Columbus Venture Partners +1 more

Explore the full BIO-Europe 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Cologne. Leave your work email and we’ll be in touch.

Privacy

Download the full BIO-Europe 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from Oxford BioTherapeutics

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by BIO-Europe or its organizers. Submit a correction